
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
A REVIEW OF KETOROLAC AS A POTENTIAL THERAPEUTIC AGENT
Bande Shaila*, Bade Vaishnavi and Nilesh Y. Jadhav
. Abstract When treating acute pain, non-steroidal anti-inflammatory medications (NSAIDs) might be a part of a multimodal strategy. When NSAIDs are administered via intramuscular (IM) or intravenous (IV) injection, patients who are nil-by-mouth or who are unable to swallow can benefit from the medication's quicker onset than when taken orally. An intramuscular (IM) or IV injection can be used to deliver the NSAID. Additionally, ketorolac has been used to treat a number of illnesses, including cancer, analgesics, antipyretics, and inflammation. When administered either by alone or in combination with other medicines as part of a multimodal approach to analgesia, it is a useful analgesic. This article examines the research on the effectiveness and safety of ketorolac as an analgesic for acute pain from peer-reviewed journals and current clinical guidelines. Keywords: Ketorolac, analgesic, Anti-inflammatory, anti-cancer, Pain. [Full Text Article] [Download Certificate] |
